Literature DB >> 12573199

Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention.

David J Hyman1, Valory N Pavlik.   

Abstract

Hypertension is the most widely treated cardiovascular risk factor, and there is clear evidence of the efficacy of treating systolic and diastolic blood pressure with existing antihypertensive agents in reducing stroke and cardiac disease. However, only about 25% of the US population has blood pressure controlled to at least 140 mm Hg systolic and 90 mm Hg diastolic. Hypertension control is a complex function of patient and physician behavior. Although poor hypertension control has historically been attributed to lack of health insurance or low utilization of available services, recently published analyses of national survey data and local physician and community samples suggest that physicians have a permissive attitude toward isolated mild systolic blood pressure elevations in the range of 140 to 160 mm Hg. The great majority of participants in health surveys report seeing a physician at least two times per year, and several investigators have documented that physicians are unlikely to increase treatment intensity for systolic elevations alone. Physician inaction toward elevated systolic blood pressure may be due to a reluctance to prescribe multiple drugs and/or lack of belief in the benefits of aggressive treatment to lower systolic blood pressure below 140 mm Hg.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573199     DOI: 10.1007/s11883-003-0085-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  38 in total

1.  Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study.

Authors:  R A Preston; B J Materson; D J Reda; D W Williams
Journal:  Arch Intern Med       Date:  2000-05-22

2.  Treatment of warfarin-associated coagulopathy: a physician survey.

Authors:  S E Wilson; J D Douketis; M A Crowther
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

3.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

4.  Physician knowledge, attitudes and practices regarding a widely implemented guideline.

Authors:  Marcia M Ward; Thomas E Vaughn; Tanya Uden-Holman; Bradley N Doebbeling; William R Clarke; Robert F Woolson
Journal:  J Eval Clin Pract       Date:  2002-05       Impact factor: 2.431

5.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

6.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

Review 7.  Statins and blood pressure regulation.

Authors:  C Borghi; M Veronesi; M G Prandin; A Dormi; E Ambrosioni
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

8.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

9.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

10.  Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension.

Authors:  Kathryn E Ferrier; Michael H Muhlmann; Jean Philippe Baguet; James D Cameron; Garry L Jennings; Anthony M Dart; Bronwyn A Kingwell
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

View more
  3 in total

1.  Impact of computerized decision support on blood pressure management and control: a randomized controlled trial.

Authors:  Leroi S Hicks; Thomas D Sequist; John Z Ayanian; Shimon Shaykevich; David G Fairchild; E John Orav; David W Bates
Journal:  J Gen Intern Med       Date:  2008-04       Impact factor: 5.128

2.  Determinants of racial/ethnic differences in blood pressure management among hypertensive patients.

Authors:  LeRoi S Hicks; Shimon Shaykevich; David W Bates; John Z Ayanian
Journal:  BMC Cardiovasc Disord       Date:  2005-06-22       Impact factor: 2.298

3.  Racial/ethnic disparity in the associations of smoking status with uncontrolled hypertension subtypes among hypertensive subjects.

Authors:  Xuefeng Liu; Tinghui Zhu; Milisa Manojlovich; Hillel W Cohen; Dennis Tsilimingras
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.